EV Biologics, Inc. (YECO)

USD 0.14

(0.0%)

Market Cap (In USD)

1.03 Million

Revenue (In USD)

48.9 Thousand

Net Income (In USD)

-1.26 Million

Avg. Volume

624.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.102-1.0
PE
-
EPS
-
Beta Value
0.390943
ISIN
US9884971030
CUSIP
988497103
CIK
1607741
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Daniel S. McKinney
Employee Count
-
Website
https://www.evbiologics.com
Ipo Date
2015-06-29
Details
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.